A

ANIK

ANIK

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
50%Neutral
Buy/Sell Ratio100% buys
BearishBullish
ANIK Live QuoteReal-time
$13.28
$7.32(-35.53%)1M
Day Range$13.20 – $14.06
Open$13.59
Previous Close$13.62
Volume147.4K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$177.89M
P/E Ratio (TTM)24.5
Forward P/E13.6
EPS (TTM)$-0.03
Price to Book1.3
Dividend Yield0.65%
Beta (Volatility)0.20
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
52-Week RangeCurrent: $13.28 (31%)
Low: $9.01High: $22.88
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$20.00-86.7% upside

Insider Buys

3

$264K

Insider Sales

0

$0

Total Volume

$264K

6 transactions

Net Activity

+$264K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys3 sells

$823.57M total

G
2

Griffin Stephen D.

Pres, CEO

1 buys0 sells

$150K total

H
3

Henneman John B III

Dir

1 buys0 sells

$73K total

F
4

Fischetti Gary P

Dir

1 buys0 sells

$41K total

Trading History
ANIK insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 3, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell54.0K$2000.00$108.03M

Aug 3, 2026

3 months ago

Fischetti Gary P

Dir

Director
Buy2.0K$20.53$41K

May 1, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell54.9K$5000.00$274.36M

May 1, 2026

6 months ago

Henneman John B III

Dir

Director
Buy5.0K$14.66$73K

Apr 30, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell36.2K$12200.00$441.19M

Apr 30, 2026

6 months ago

Griffin Stephen D.

Pres, CEO

CEO
Buy12.2K$12.29$150K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ANIK Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

ANIK has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ANIK

Over the last 90 days, corporate insiders at ANIK (ANIK) engaged in a total of 6 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 0 were sales. The total volume of insider trading reached $264K.

The net insider activity for ANIK shows a net buying bias of $264K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 36.2K shares valued at $441.19M on Apr 30, 2026.

Live Market News & Developments
Aggregated real-time headlines for ANIK (ANIK)
6 updates

(ANIK) Risk Channels and Responsive Allocation

Stock Traders Daily21h ago

Anika Therapeutics (ANIK) Beats Q3 Earnings and Revenue Estimates

Yahoo Finance14d ago

ANIK - Anika Therapeutics Inc Stock Price and Quote

Finviz177d ago

$ANIK stock is down 22% today. Here's what we see in our data.

Quiver Quantitative13d ago

Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why

Yahoo Finance88d ago

Bullish On Anika Therapeutics’s Pullback As Integrity Scales (NASDAQ:ANIK)

Seeking Alpha204d ago

FAQs About ANIK Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ANIK.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ANIK is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 3 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for ANIK is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.